Short Interest Data Reveals Investor Sentiment in Healthcare Sector
At the end of September 2026, short interest data revealed a wide range of investor sentiment across mid-to mega-cap healthcare stocks. The most heavily shorted names were primarily clinical-stage biotechnology and health equipment companies known for high volatility, such as Recursion Pharmaceuticals (RXRX) and Strive (ASST). This suggests significant bearish expectations among investors toward these firms. In contrast, other healthcare stocks with lower short interest indicate more bullish or neutral investor sentiment. The disparity in short positions reflects differing market views on the sector’s future performance, particularly between high-risk biotech ventures and more stable pharmaceutical or medical device companies.
Topics: biotechnology healthcare sector market sentiment short interest